Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NIASPAN
- Assessment Of Vascular Health After Niacin Therapy (AVANT)
- Effects of Niacin On Fatty Acid Trapping
- Benefit of Elevation of HDL-C in Women
- Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions
- Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis
- Biosynthesis of PGD2 in Vivo
- Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
- Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia
- Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America
- Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
- Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid
- A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093)
- Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)
- Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels
- The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
- Role of Prostaglandins on Niacin-Induced Flushing
- Study to Test GSK256073 in Patients With Dyslipidemia
- Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome
- Niacin and Endothelial Function in Early CKD
- Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery
- A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)
- Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
- Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
- Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
- Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)
- Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)
- Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin
- Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia
- Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women
- MK0524A Phase IIb Study (0524A-011)(COMPLETED)
- Endpoint Validation Study (0524A-015)
- MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED)
- High-Density Lipoprotein (HDL) Treatment Study
- Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
- Niacin, N-3 Fatty Acids and Insulin Resistance
- Obesity and Nonalcoholic Fatty Liver Disease
- The Low HDL On Six Weeks Statin Therapy (LOW) Study
- Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function
- High-Density Lipoprotein (HDL) Modulation and Endothelial Function
- Niacin Plus Statin to Prevent Vascular Events
- Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy
- Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
- The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC
- Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication
- Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
Clinical trials list
click for details